9,790
Views
17
CrossRef citations to date
0
Altmetric
Editorial

Estetrol (E4): the new estrogenic component of combined oral contraceptives

ORCID Icon, , ORCID Icon &
Pages 327-330 | Received 13 Dec 2019, Accepted 27 Mar 2020, Published online: 07 Apr 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Christian Battipaglia, Lia Feliciello, Alessandro D. Genazzani, Fabio Facchinetti & Giovanni Grandi. (2023) Combined oral contraceptive with estetrol plus drospirenone: from pharmacokinetics to clinical applications. Expert Opinion on Drug Metabolism & Toxicology 0:0, pages 1-9.
Read now
Kristina Gemzell-Danielsson, Angelo Cagnacci, Nathalie Chabbert-Buffet, Jonathan Douxfils, Jean-Michel Foidart, Ali Kubba, Luis Ignacio Lete Lasa, Diana Mansour, Joseph Neulen, Jaoquim Neves, Fátima Palma, Thomas Römer, Robert Spaczyński & Vera Tóth. (2022) A novel estetrol-containing combined oral contraceptive: European expert panel review. The European Journal of Contraception & Reproductive Health Care 27:5, pages 373-383.
Read now
Giovanni Grandi, Fabio Facchinetti & Johannes Bitzer. (2022) Confirmation of the safety of combined oral contraceptives containing oestradiol on the risk of venous thromboembolism. The European Journal of Contraception & Reproductive Health Care 27:2, pages 83-84.
Read now
Giovanni Grandi, Maria Chiara Del Savio & Fabio Facchinetti. (2021) The paradigm of norgestimate: a third-generation testosterone-derivative progestin with a peripheral anti-androgenic activity and the lowest risk of venous thromboembolism. Expert Review of Clinical Pharmacology 14:2, pages 211-224.
Read now
Herjan Jt Coelingh Bennink. (2020) Letter to the editor regarding ‘Estetrol (E4): the new estrogenic component of combined oral contraceptives’. Expert Review of Clinical Pharmacology 13:11, pages 1281-1281.
Read now

Articles from other publishers (12)

Brooke E Barton, Jeffery A Erickson, Stephanie I Allred, Jenna M Jeffries, Kalli K Stephens, Mark I Hunter, Kirby A Woodall & Wipawee Winuthayanon. (2023) Reversible female contraceptives: historical, current, and future perspectives. Biology of Reproduction.
Crossref
Thomas Römer. (2023) Übersicht zu hormonellen KontrazeptivaHormonal contraceptives—an overview. Die Gynäkologie 56:9, pages 587-596.
Crossref
Pauline Bianchi, Amaury Dubart, Maurane Moors, Damien Cornut, Gilbert Duhirwe, Jordi Ampurdanés Vilanova & Jean-Christophe M. Monbaliu. (2023) Metal-free synthesis of an estetrol key intermediate under intensified continuous flow conditions. Reaction Chemistry & Engineering 8:7, pages 1565-1575.
Crossref
Daniel Patiño-García, Jaime Palomino, Cristián Pomés, Claudia Celle, Verónica Torres-Estay & Renán Orellana. (2023) Estetrol Increases Progesterone Genetic Response without Triggering Common Estrogenic Effects in Endometriotic Cell Lines and Primary Cultures. Biomedicines 11:4, pages 1169.
Crossref
Marina de Oliveira Gadelha Souza, Kelli Costa Souza, Ankilma do Nascimento Andrade Feitosa, Rodolfo de Abreu Carolino, Ocilma Barros de Quental & Gardson Marcelo Franklin de Melo. (2023) VANTAGENS DO ESTETROL FRENTE AOS OUTROS ESTROGÊNIOS DAS PÍLULAS CONTRACEPTIVAS: REVISÃO INTEGRATIVA. Revista interdisciplinar em saúde 10:Único, pages 12-24.
Crossref
Meijun Pan, Jing Zhou, Xinyao Pan, Jing Wang, Qing Qi & Ling Wang. (2023) Drugs for the treatment of postmenopausal symptoms: Hormonal and non-hormonal therapy. Life Sciences 312, pages 121255.
Crossref
Alessandra Graziottin, Angela Cuccarollo, Stefano Uccella & Massimo P. Franchi. (2022) Estrogeni e infiammazione. L'Endocrinologo 23:3, pages 281-289.
Crossref
T.N. Bebneva, M.B. Khamoshina & V.E. Radzinsky. (2022) Estetrol is a new estrogen with selective tissue activity in the composition of a combined oral contraceptive. Problemy reproduktsii 28:6, pages 133.
Crossref
Laure Morimont, Hélène Haguet, Jean-Michel Dogné, Ulysse Gaspard & Jonathan Douxfils. (2021) Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk. Frontiers in Endocrinology 12.
Crossref
Amy J. Voedisch & Wing Kay Fok. (2021) Oestrogen component of COCs: have we finally found a replacement for ethinyl estradiol?. Current Opinion in Obstetrics & Gynecology 33:6, pages 433-439.
Crossref
Konrad Wojnarowski, Paweł Podobiński, Paulina Cholewińska, Jakub Smoliński & Karolina Dorobisz. (2021) Impact of Estrogens Present in Environment on Health and Welfare of Animals. Animals 11:7, pages 2152.
Crossref
Nancy King Reame. (2020) Estetrol for menopause symptoms: the Cinderella of estrogens or just another fairy tale?. Menopause 27:8, pages 841-843.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.